Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anticoagulants Market
Anticoagulants Market Size
- Report ID: GMI4967
- Published Date: Jun 2023
- Report Format: PDF
Anticoagulants Market Size
Anticoagulants Market size accounted for more than USD 39.2 billion in 2022 and is estimated to grow at a CAGR of over 9.5% from 2023 to 2032. Driven by the surging occurrence of chronic disorders worldwide.
Rising prevalence of chronic disorders such as deep vein thrombosis, and cardiovascular diseases which lead to blood clot formation has increased the need for anticoagulants. As per CDC, although the precise number of people diagnosed with deep vein thrombosis remains obscure, the condition can affect around 900,000 people every year in the U.S. alone. Moreover, the rising adoption of novel oral anticoagulants (NOACs) will further create a plethora of opportunities for market expansion. Benefits such as the rapid onset action, shorter half-life, and predictable pharmacokinetic action, have bolstered the adoption of NOACs.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Anticoagulants Market Size in 2022: | USD 39.2 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 9.8% |
| 2032 Value Projection: | USD 95.2 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 181 |
| Tables, Charts & Figures: | 276 |
| Segments covered: | Drug Category, Route of Administration, Application, Distribution Channel and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Anticoagulants Market Scope
